The global Hypoparathyroidism Treatment Market was valued at USD 1.25 billion in 2023 and is projected to experience substantial growth, reaching USD 2.25 billion by 2032. With a robust compound annual growth rate (CAGR) of 6.8% during the forecast period from 2024 to 2032, the market for hypoparathyroidism treatments is expected to grow significantly due to rising incidences of the disorder,...